Lisa Earnhardt, Director at Intersect ENT, holds 61.46K shares in Abbott Laboratories (Ticker: ABT), holds 379.37K shares in Intersect ENT (Ticker: XENT), holds 5.30K shares in Nevro Corp (Ticker: NVRO). Most recently, Lisa Earnhardt Sold ― shares of Abbott Laboratories on May 08, 2024 for an estimated value of 2.43M.
What is the percentage of profitable transactions made by Lisa Earnhardt?
The percentage of profitable transactions made by Lisa Earnhardt is 100%.
What is the average return per transaction made by Lisa Earnhardt?
The average return per transaction made by Lisa Earnhardt is 8.10%.
What stocks does Lisa Earnhardt hold?
Lisa Earnhardt holds: XENT, ABT, NVRO stocks.
What was Lisa Earnhardt’s latest transaction?
Lisa Earnhardt latest transaction was an Informative Sell of $2.43M.
What was Lisa Earnhardt's most profitable transaction?
Lisa Earnhardt’s most profitable transaction was an Informative Sell of ABT stock on March 4, 2024. The return on the trade was 14.10%.
What is Lisa Earnhardt's role in Intersect ENT?
Lisa Earnhardt's role in Intersect ENT is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.